Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 246-896-9 | CAS number: 25360-10-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key data were identified to evaluate the acute oral, dermal, and inhalation toxicity potential of 1,1-dimethylheptanethiol. The key parameters are discussed below:
• Acute oral LD50: 5550 mg/kg bw
• Acute dermal LD50: >2000 mg/kg bw
• Acute inhalation LC50: >7.04 mg/L
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 5 550 mg/kg bw
Additional information
Acute Oral Toxicity
One key acute study in the rat was identified to evaluate the oral toxicity potential of 1,1-dimethylheptanethiol.
In a key acute oral toxicity study (Latven, 1977a; Klimisch score = 2), groups of male WBS/W rats (5/dose) were orally administered (via gavage) a single dose of 1,1-dimethylheptanethiol at 3536, 5000, 7071, or 10,000 mg/kg bw. Animals were subsequently observed for a period of 7 days.
Motor inactivity, disorientation, and lack of co-ordination were observed at 24 and 48 hours for all groups. Body weight losses were observed for several days among survivors, but recovery was observed 5 or 6 days after treatment. Autopsies revealed probable hepatic and renal pathology. 40% mortality was observed at 5000 mg/kg; 80% at 7071 mg/kg; and100% mortality was observed in rats that received 1,1-dimethylheptanethiol at 10,000 mg/kg bw. The oral LD50 in male rats was determined to be 5550 mg/kg.
Acute Inhalation Toxicity
Two key acute studies in the rat were identified to evaluate the inhalation toxicity potential of 1,1-dimethylheptanethiol.
In a key acute inhalation toxicity study (Collins, 1987; Klimisch score = 1), Crl:CD(SD)BR strain rats (5/sex) were exposed via inhalation (head only) to 1,1-dimethylheptanethiol for 4.5 hours at a concentration of 7.04 mg/L. Animals were subsequently observed for a period of 14 days. No mortality was observed in either male or female rats through the course of the study. Marked clinical signs of pilo-erection, ataxia, transient salivation and wet fur were observed for all treated animals. These signs were not apparent in control animals. No treatment-related effects on body weight were observed in either male or female rats. No gross or histopathological signs of specific organ toxicity were observed in any of the treated animals. Based on the lack of treatment-related signs of clinical toxicity, the acute inhalation LC50 for 1,1-dimethylheptanethiol was determined to be >7.04 mg/L (7041 mg/m3 or 1074 ppm).
In a second key acute inhalation toxicity study (Hardy and Jackson, 1987; Klimisch socre = 1), young adult Sprague-Dawley rats (5/sex/dose) were exposed to 1,1-dimethylheptanethiol vapour via the inhalation route (whole body) at a concentration of 1.97 mg/L for a period of 4 hours.Animals were subsequently observed for a period of 14 days. No mortality was observed in either male or female rats exposed to 1,1-dimethylheptanethiol. Signs observed during exposure included closing or partial closing of the eyes, disturbances to the respiratory pattern, and adoption of a hunched body posture. These effects were attributed to the irritant nature of the vapour. Immediately subsequent to exposure, all rats in the exposed group were ataxic and had a slow respiratory pattern. All rats seemed normal in behavior and appearance after Day 1 of the post-exposure observation period. No adverse treatment-related effects on bodyweight gain were observed through the study period and macroscopic pathology did not reveal any remarkable findings. Based on the lack of adverse signs of toxicity, the acute inhalation LC50 for 1,1-dimethylheptanethiol was determined to be >1.97 mg/L (1970 mg/m3 or 300 ppm) in rats.
Acute Dermal Toxicity
One key acute study in the rat was identified to evaluate the dermal toxicity potential of 1,1-dimethylheptanethiol.
In an acute dermal toxicity study (Latven, 1977b; Klimisch score = 2), 6 male WBS/W rats were dermally administered a single dose of 1,1-dimethylheptanethiol at 2000 mg/kg bw. A pre-fitted occlusive sleeve was then placed on each animal and remained in place for 24 hours. The animals were subsequently observed for a period of 7 days.
None of the animals exhibited any clinical symptoms and no mortality was observed through the study period. Some loss in body weight was observed but had recovered one day later. Based on the lack of observed adverse toxicity effects, the acute dermal LD50 for 1,1 -dimethylheptanethiol was determined to be >2000 mg/kg bw.
Justification for classification or non-classification
1,1-dimethylheptanethiol does not meet the criteria for classification as an acute oral toxicant under EU Dangerous Substances Directive 67/548/EEC or CLP EU Regulation 1272/2008.
1,1-dimethylheptanethiol does not meet the criteria for classification as an acute dermal toxicant under EU Dangerous Substances Directive 67/548/EEC or CLP EU Regulation 1272/2008.
1,1-dimethylheptanethiol does not meet the criteria for classification as an acute inhalation toxicant under EU Dangerous Substances Directive 67/548/EEC or CLP EU Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.